መነሻ › የኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) › ሚዙሪ › St. Louis
በSt. Louis፣ MO ለየኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) የሚደረጉ ክሊኒካዊ ጥናቶች
ለየኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) የሚደረጉ 23 ጥናቶች በSt. Louis እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Washington University Medicine, St Louis
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Washington University School of Medicine, St Louis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- እና 4 ተጨማሪ
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Washington University in St. Louis, St Louis
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- እና 5 ተጨማሪ
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Washington University, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Washington University, St Louis
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Washington University School of Medicine ( Site 0114), St Louis
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Washington University School of Medicine, St Louis
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Washington University School of Medicine, St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Washington University, St Louis
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · 16 ማይል ርቀት
- እና 1 ተጨማሪ
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- እና 5 ተጨማሪ
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- እና 6 ተጨማሪ
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, St Louis
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Washington University School of Medicine, St Louis
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Missouri Baptist Medical Center, St Louis
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Washington University School of Medicine, St Louis
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Siteman Cancer Center, Washington University, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Washington University Medical Campus, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Washington University, St Louis
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Saint Louis Cancer and Breast Institute-South City, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- እና 4 ተጨማሪ
በሌሎች ከተሞች ለየኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) የሚደረጉ ጥናቶች
- Houston, TX35 ጥናቶች
- New York City, NY27 ጥናቶች
- Nashville, TN23 ጥናቶች
- Dallas, TX23 ጥናቶች
- Los Angeles, CA20 ጥናቶች
- Boston, MA16 ጥናቶች
- Baldwin Park, CA16 ጥናቶች
- Philadelphia, PA15 ጥናቶች
- Pittsburgh, PA15 ጥናቶች
- Queens, NY15 ጥናቶች
- Rochester, MN14 ጥናቶች
- Cleveland, OH14 ጥናቶች
በSt. Louis ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር73 ጥናቶች
- የጡንቻ ካንሰር64 ጥናቶች
- Metastatic Cancer54 ጥናቶች
- የኮሎሬክታል ካንሰር50 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)46 ጥናቶች
- የፕሮስቴት ካንሰር46 ጥናቶች
- የሳንባ ካንሰር39 ጥናቶች
- የእንቁላል ካንሰር38 ጥናቶች
- የፓንክሪያስ ካንሰር33 ጥናቶች
- የኤንዶሜትሪየም ካንሰር29 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ28 ጥናቶች
- የልብ ድካም26 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።